Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / S&P PHARMAC
-
Total 13F shares
-
2,842,974
-
Share change
-
+781,121
-
Total reported value
-
$116,547,963
-
Put/Call ratio
-
1533%
-
Price per share
-
$40.99
-
Number of holders
-
58
-
Value change
-
+$32,000,661
-
Number of buys
-
16
-
Number of sells
-
30
Institutional Holders of SPDR SERIES TRUST - S&P PHARMAC (XPH) as of Q2 2023
As of 30 Jun 2023 SPDR SERIES TRUST - S&P PHARMAC (XPH) had 58 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,842,974 shares of stock of the company.
Largest 10 holders included Clal Insurance Enterprises Holdings Ltd, MORGAN STANLEY, GOLDMAN SACHS GROUP INC, BANK OF AMERICA CORP /DE/, LPL Financial LLC, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, FIRST CITIZENS BANK & TRUST CO, ENVESTNET ASSET MANAGEMENT INC, MAI Capital Management, and WELLS FARGO & COMPANY/MN.
This table shows 58 institutional shareholders of the security as of 30 Jun 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.